Mallinckrodt Pharmaceutical’s recently received the APICS Corporate Award of Excellence in Transformation at its flagship conference in San Antonio, Texas. Companies around the world compete for the award, which is given each year to an organization that demonstrates improved business and supply chain performance by using APICS’ supply chain best practices. The association has more than 45,000 professional members across 100 countries.
Developing a fully integrated supply chain that reflects Mallinckrodt’s focus on quality and service as a partner of integrity has been a major goal since becoming an independent company in 2013. Mallinckrodt’s Specialty Generics business has transformed its competitive positioning dramatically over the last several years by instituting a series of improvements to its supply chain and manufacturing processes. Efforts have been underway across all manufacturing sites to identify measures to improve customer service, inventory control and become more agile in responding to changing customer demands.
“We now have a world-class supply chain that sets a high industry bar,” said Steve Richards, Vice President of Manufacturing for Mallinckrodt’s Specialty Generics. “That didn’t happen overnight. We attacked challenges one at a time. It involved collaboration across the business—including supply chain, manufacturing, finance, sales, quality and the shop floor—to identify and execute high-impact solutions. This is award validates the substantial progress we’ve made.”
APICS is a global association for supply chain management and a leading provider of research, education and certification programs that elevate supply chain excellence, innovation and resilience. http://www.apics.org/
Photo caption from left: Abe Eshkenazi, Chief Executive Officer, APICS; David Widder, Senior Director, Supply Chain Planning and C.S. Compliance; Kimberly Pape, Manager, Supply Chain Planning; Dan Gorke, Manager, Supply Chain Planning; Steve Georgevitch, Chair, APICS Board of Directors.